A schematic cut-away of facial skin with rosacea, not to scale. A thin film of Rocelix Cream lies on the surface. Under a thin stratum corneum, where small dots show water escaping through a weak barrier, the epidermis sits over a dermis whose superficial arterioles, cut across, are wide open. Capillary loops rise towards the epidermis, immune cells cluster around the vessels, mast cells sit nearby, and a red glow shows the persistent redness. Each active is a shape that travels from the film: oxymetazoline a circle heading to the arterioles, niacinamide a triangle heading to the epidermis.
Inset A enlarges the barrier. Niacinamide enters a granular keratinocyte and feeds its NAD⁺ pool; striped lamellar bodies fuse with the cell's top membrane and release lipid into the gaps between corneocytes, thickening the mortar so less water escapes.
Inset B enlarges an arteriole wall. Oxymetazoline binds the α1A-adrenoceptor on a smooth muscle cell; the receptor activates Gq and phospholipase C, IP₃ releases calcium from the sarcoplasmic reticulum, the muscle contracts and the vessel narrows, so fewer red blood cells pass near the surface.
The buttons below turn each active on or off in a teaching model. Without oxymetazoline the arterioles stay dilated and the redness stays high; without niacinamide the barrier stays weak and more water escapes. These are directions of effect, not measured amounts.